SC
NVO

Sepio Capital’s Novo Nordisk NVO Stock Holding History

Sepio Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.3M Buy
35,426
+2,918
+9% +$138K 0.07% 148
2025
Q4 		$1.65M Sell
32,508
-1,079
-3% -$55.2K 0.09% 125
2025
Q3 		$1.86M Buy
33,587
+6,196
+23% +$363K 0.11% 114
2025
Q2 		$1.89M Buy
27,391
+32
+0.1% +$2.18K 0.13% 107
2025
Q1 		$1.9M Buy
27,359
+7,455
+37% +$616K 0.15% 108
2024
Q4 		$1.71M Sell
19,904
-138
-0.7% -$14.9K 0.14% 119
2024
Q3 		$2.39M Sell
20,042
-154
-0.8% -$20.5K 0.19% 98
2024
Q2 		$2.88M Sell
20,196
-78
-0.4% -$10.3K 0.26% 79
2024
Q1 		$2.6M Sell
20,274
-1,970
-9% -$235K 0.22% 92
2023
Q4 		$2.3M Sell
22,244
-3,461
-13% -$342K 0.19% 95
2023
Q3 		$2.34M Buy
25,705
+319
+1% +$28.1K 0.2% 103
2023
Q2 		$2.05M Sell
25,386
-1,016
-4% -$83K 0.17% 144
2023
Q1 		$2.1M Sell
26,402
-4,054
-13% -$287K 0.19% 137
2022
Q4 		$2.06M Sell
30,456
-4,628
-13% -$271K 0.18% 147
2022
Q3 		$1.75M Sell
35,084
-1,404
-4% -$75.2K 0.17% 143
2022
Q2 		$2.03M Sell
36,488
-1,204
-3% -$66.8K 0.2% 138
2022
Q1 		$2.09M Sell
37,692
-2,666
-7% -$137K 0.18% 151
2021
Q4 		$2.26M Buy
40,358
+92
+0.2% +$4.98K 0.17% 161
2021
Q3 		$1.93M Buy
40,266
+188
+0.5% +$9.09K 0.16% 170
2021
Q2 		$1.68M Sell
40,078
-4,590
-10% -$178K 0.14% 188
2021
Q1 		$1.51M Buy
+44,668
New +$1.59M 0.14% 184
2019
Q3 		– Sell
-143,208
Closed -$3.65M – 269
2019
Q2 		$3.65M Sell
143,208
-704
-0.5% -$17.4K 0.49% 61
2019
Q1 		$3.76M Sell
143,912
-19,720
-12% -$485K 0.51% 55
2018
Q4 		$3.77M Buy
+163,632
New +$3.64M 0.27% 68

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Sepio Capital's NVO Position: Q1 2026 in Review

Sepio Capital increased its Novo Nordisk (NVO) stake by 9% in Q1 2026, buying an estimated $138K and bringing the position to 35,426 shares worth $1.3M. The position accounts for 0.07% of the portfolio, ranked #148.

Sepio Capital first reported a position in NVO in Q4 2018 and has held it in 24 quarters since. The position peaked at $3.77M in Q4 2018. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Sepio Capital held 35,426 shares of Novo Nordisk worth $1.3M as of Q1 2026.
  • Sepio Capital bought 2,918 Novo Nordisk shares in Q1 2026, an estimated $138K.
  • Novo Nordisk made up 0.07% of Sepio Capital's portfolio in Q1 2026, its #148 holding.
  • Sepio Capital first reported a position in Novo Nordisk in Q4 2018 and has held it in 24 quarters since.
  • Sepio Capital's Novo Nordisk position peaked at $3.77M in Q4 2018.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Sepio Capital's 13F filing for Q1 2026, filed 13 May 2026.